U.S. market Closed. Opens in 1 day 4 hours 59 minutes

BNGO | Bionano Genomics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue36.12M27.80M17.98M8.50M10.13M12.00M9.51M6.79M
Cost of Revenue26.55M21.86M14.11M5.73M6.77M8.71M6.03M3.58M
Gross Profit9.57M5.95M3.87M2.77M3.36M3.29M3.47M3.21M
Operating Expenses224.81M137.64M80.97M41.32M29.24M23.70M26.09M24.38M
Selling, General & Admin94.96M88.60M58.49M31.07M20.16M14.22M14.08M12.95M
Research & Development54.03M49.05M22.48M10.26M9.08M9.48M12.01M11.43M
Other Operating Expenses75.82M-223.00K-59.00K-2.56M-3.94M-675.85K-289.01K-203.28K
Operating Income-215.25M-131.70M-77.10M-38.55M-25.87M-20.42M-23.22M-21.17M
Other Expenses / Income-17.19M986.00K-1.05M-2.53M-3.92M1.93M-128.00K2.33M
Before Tax Income-232.43M-130.71M-78.15M-41.11M-29.82M-18.48M-23.35M-18.84M
Income Tax Expenses62.00K1.88M-5.72M29.19K21.05K15.51K18.55K12.92K
Net Income-232.49M-132.60M-72.44M-41.14M-29.84M-18.50M-23.37M-18.85M
Interest Expenses5.12M298.00K927.00K2.52M2.29M1.38M590.93K470.07K
Basic Shares Outstanding34.15M28.92M27.68M10.43M1.50M707.71K270.11K522.74K
Diluted Shares Outstanding34.15M28.92M27.68M10.43M1.50M707.71K270.11K522.74K
EBITDA-213.60M-120.31M-73.86M-37.08M-26.38M-15.78M-21.25M-17.25M
EBITDA Margin-591.44%-432.76%-410.74%-436.12%-260.43%-131.49%-223.58%-253.95%
EBIT-227.31M-130.41M-77.22M-38.59M-27.53M-17.10M-22.76M-18.37M
EBIT Margin-629.39%-469.08%-429.48%-453.81%-271.77%-142.49%-239.41%-270.37%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙